Designed with the patient in mind, decentralized clinical trials (DCTs) are changing how we conduct clinical trials, and they bring research to your doorstep or close to home. Whether a trial is fully decentralized or hybrid, patients may benefit from: - Convenient access with less travel - Personalized support with frequent communication - Additional care options with advanced technology Interested in participating in a DCT? Learn what to expect and read some example patient journeys in our latest blog post: https://lnkd.in/gFEw_ikb #clinicalresearch #remote #DCT #hybrid
Circuit Clinical
Research Services
Buffalo, New York 3,994 followers
An IRO committed to better access to clinical research, the development of new medicines, and health equity.
About us
Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com
- Website
-
http://www.circuitclinical.com
External link for Circuit Clinical
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Buffalo, New York
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site Network, Patient Network with EMR Access , Clinical Trials, Clinical Research, Western New York, Patient Referral Screening, Western Kentucky, Madison, Wisconsin, Northern New Jersey, Clinical Research, Clinical Research Operations, Western Philadelphia Suburbs, and Hudson Valley New York
Locations
-
Primary
599 Delaware Avenue
Buffalo, New York 14202, US
-
MB9 Galleria PH North
720 S Colorado Blvd
Denver, Colorado 80246, US
Employees at Circuit Clinical
Updates
-
Earlier this summer, Moderna announced that their RSV vaccine, mRESVIA, received FDA approval. This significant milestone means we are one step closer to bringing this life-saving treatment to the broader population, a feat that we can all be proud of. In collaboration with the principal investigators at our research location in northern New Jersey, our Team supported this RSV vaccine Phase 2/3 study and achieved a 96% retention rate for participants, ranking us in the top 4 globally for retention and placing us in the top 1.5% of all participating sites. This study, among other vaccine studies, has made vaccine research a cornerstone for our New Jersey Team, which consistently delivers on hitting enrollment goals and ensuring that patients feel informed and comfortable with their research participation. Learn more about this momentous achievement for Moderna and how we are doing our part in medical advancement for all: https://lnkd.in/gVcjQGsg #clinicalresearch #FDAapproval
-
-
Our Northern New Jersey Team has had a busy August—they have attended five community events in the past two weeks! Community events are an incredible way for our Team to get out into the communities that they serve and help spread awareness of clinical research. They directly tie into our mission of embedding ourselves in new communities to bring access to clinical research. Whether people are interested in participating in a trial with their trusted physicians or want to learn about the benefits of research, our Team is ready (with swag in tow). #community #clinicalresearch
-
-
We are happy to announce that we have expanded our Site Partnership Network with the newest physician group: Mercer Allergy & Pulmonary Associates, LLC Mercer Allergy & Pulmonary Associates is a premier allergy and pulmonary care provider in Hamilton Township, New Jersey. With this collaboration, we aim to improve community access to innovative treatments through clinical trials in central New Jersey; and by partnering, we enhance medical services for patients and the surrounding residents through an embedded traditional research model. "Our commitment to providing high-quality care is at the core of everything we do. We are excited to offer our patients new and potentially life-changing treatments by partnering with Circuit Clinical...” — Dr. Anthony J. Ricketti, Founder and Lead Physician at Mercer Allergy & Pulmonary Associates. Read more below: https://lnkd.in/e6GWsymH #clinicalresearch #partnership
-
-
Part of providing clinical trial access to people nationwide is partnering with incredible physicians who have trusted relationships with their patients. One of those physicians is Dr. Isha Gupta from Middletown Medical. This health system is part of our Site Partnership Network in Hudson, NY. Dr. Gupta is board-certified in nephrology and internal medicine. We sat down with her to ask her ten questions about how she became involved in clinical research and her thoughts about the healthcare industry. Learn more about what drives her to remain dedicated, compassionate, and community-oriented. https://lnkd.in/eW2SCpWf #clinicalresearch #physician
-
-
Our Team is passionate about many things: helping people find care options with clinical trials, providing next-level support to physicians getting started in research, and playing our part in advancing medicine. Another thing we're passionate about—our pets! For "Bring Your Pet to Work" day, we all got to feature our furry friends on camera! From wagging tails to smiling faces, it was a great way to start the day. #team #culture
-
-
Last month, our Western New York clinical research team attended a festival celebrating Juneteenth. Despite record-breaking heat, they were able to meet with people in the community and spread awareness of the benefits of clinical research—with ice packs and freeze pops in tow! "Being out in the community was rewarding, and we can't wait for our next event!" — Erika Barba, S.T., Regional Site Director of WNY #communityhealthcare
-
-
One of our Western New York site partners was involved in the early phase trials of a new treatment for hot flashes known as Veozah®. In collaboration with our clinical research experts embedded within this site, the physicians who have trusted relationships with their patients, and the industry-leading pharmaceutical company that sponsored the trial, we were able to enroll participants and contribute to the medical understanding of this drug—ultimately leading to FDA approval. Read more about this new treatment, the part we played in achieving FDA approval, and how we are supporting women's health and inclusivity in clinical research: https://lnkd.in/ecVaaAc5 #clinicalresearch #FDAapproval #womenshealth
-
-
Moderna recently announced that they have received FDA approval for their RSV vaccine, mRESVIA; it is their second mRNA product to receive approval. Our team played a part in this incredible achievement as one of the participating research sites in the Phase 2/3 study for the vaccine. From Jose A. Flores, our Senior Site Director for our Northern New Jersey district, who led our research team in the study, “The team has been doing an amazing job...Our study team follows each participant for two years, starting with randomization. We achieved our success and recognition by Moderna because our research staff consistently followed up with patients with monthly safety calls, in-person visits, unscheduled illness visits, AEs, SAE, and weekly eDiary review completion.” We congratulate Moderna on this accomplishment and look forward to seeing more trials leading to the same outcome! Learn more about Moderna's RSV vaccine approval news here: https://lnkd.in/eRsQeXtP #clinicalresearch #FDAapproval
-
-
In just a few short days, we will be at #DIA2024 in San Diego for an exciting event with over 180 sessions spanning 13 unique tracks. Our CEO, @Irfan Khan, will be joining Krystyna Chmura, MPH (Evernorth Health Services), Earl Seltzer (CTI Clinical Trial and Consulting Services), Josh Rose (Hawthorne Effect, Inc.), and Kristen Andrews (Labcorp) in the forum, "Innovation, Agility, and Accessibility in Trial Execution: Collaboration Among Labs, Pharmacies, and Research Enablers" on June 18, 4:30 pm-5:30 pm. Learn more, and see you there! https://lnkd.in/eWPDFP7k #clinicalresearch
-